v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenues:        
Premiums $ 86,956 $ 87,905 $ 174,517 $ 174,439
Investment and other income 1,223 1,108 2,354 2,141
Total revenues 112,032 111,616 223,753 221,191
Operating costs:        
Medical Costs 75,358 78,585 148,847 151,996
Operating costs 14,268 13,778 29,658 27,372
Cost of products sold 13,375 13,019 26,198 25,409
Depreciation and amortization 1,040 1,084 2,069 2,145
Total operating costs 104,041 106,466 206,772 206,922
Earnings from operations 7,991 5,150 16,981 14,269
Interest expense (962) (1,027) (1,917) (2,025)
Loss on sale of subsidiary and subsidiaries held for sale (61) (41) (133) (56)
Earnings before income taxes 6,968 4,082 14,931 12,188
Provision for income taxes (1,298) (510) (2,780) (2,142)
Net earnings 5,670 3,572 12,151 10,046
Earnings attributable to noncontrolling interests (186) (166) (387) (348)
Net earnings attributable to UnitedHealth Group common shareholders $ 5,484 $ 3,406 $ 11,764 $ 9,698
Earnings per share attributable to UnitedHealth Group common shareholders:        
Basic $ 6.06 $ 3.76 $ 12.98 $ 10.66
Diluted $ 6.04 $ 3.74 $ 12.94 $ 10.61
Basic weighted-average number of common shares outstanding 902 907 905 910
Dilutive effect of common share equivalents 4 3 3 4
Diluted weighted-average number of common shares outstanding 906 910 908 914
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents 12 13 15 10
Products        
Revenues:        
Revenue from Products and Services $ 13,835 $ 13,564 $ 27,085 $ 26,600
Services        
Revenues:        
Revenue from Products and Services $ 10,018 $ 9,039 $ 19,797 $ 18,011